Tramag Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Other Depository Credit Intermediation | All Other Nondepository Credit Intermediation | Other Activities Related to Credit Intermediation | All Other Insurance Related Activities | Administrative Management and General Management Consulting Services | All Other Miscellaneous Ambulatory Health Care Services

Full name: Tramag Sp. z o.o.

Profile Updated: February 06, 2026

Tramag Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on May 07, 2020. From the latest financial highlights, Tramag Sp. z o.o. reported a net sales revenue increase of 4406.39% in 2025. Over the same period, its total assets grew by 175.3%.

Headquarters
Ul. Stanislawa Zaryna 2B
Warsaw; Mazowieckie; Postal Code: 02-593

Contact Details: Purchase the Tramag Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Tramag Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Tramag Sp. z o.o. report to view the information.

Incorporation Date:

May 07, 2020

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

59.05%

Purchase this report to view the information.

17.51%

Purchase this report to view the information.

13.65%

Company Performance

Financial values in the chart are available after Tramag Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

4406.39%▲

Total Operating Revenue

3976.02%▲

Operating Profit

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

175.3%▲

Total Equity

397.95%▲

Operating Profit Margin

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Similar companies